Skip to content
lifestyle.entreprenerd.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Korro Bio, Inc.
Korro to Present at the 2026 Jefferies Global Healthcare Conference in London
November 6, 2026
Korro Reports Third Quarter 2026 Financial Results and Provides Corporate Update
November 5, 2026
Korro Reports Best-in-Class Preclinical Data for KRRO-111 Demonstrating Potential to Benefit Lung and Liver Manifestations of Alpha-1 Antitrypsin Deficiency
October 22, 2026
Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 16, 2026
Korro Announces First Cohort Dosed in Phase 1/2 Clinical Trial (ANCHOR) for KRRO-121
October 5, 2026
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 11, 2026
Korro to Participate in Upcoming Investor Conferences
August 27, 2026
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 14, 2026
Korro Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 6, 2026
Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 10, 2026
1
2
Next Page
→